The BioInsights Podcast
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
The BioInsights Podcast
Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space
•
BioInsights
•
Season 4
•
Episode 1
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Róisin McGuigan, Commissioning Editor, Nucleic Acid Insights, speaks to Ketaki Deshmukh, Senior Scientist, Novo Nordisk, about advanced characterization tools for LNPs, challenges in extrahepatic delivery, scalability issues, and the potential impact of AI and machine learning (ML) on future LNP development.
What are you currently working on?
What are the key challenges for extrahepatic delivery using LNPs and the most promising avenues for achieving targeted delivery?
What would you identify as the current state-of-the-art in terms of advanced characterization tools available for LNPs?
What are the key current challenges in LNP process development?
What are the key parameters to consider when looking at successful scalability of LNPs?
When and how do you predict the industry will move forward in the LNP space and leverage nanoparticle delivery?
What are your own key goals and priorities for the next few years?